Skip to main content
Caplight Logo









EnPlusOne Biosciences

EnPlusOne Biosciences

Private
Watertown, MassachusettsHealthcare & Life Scienceshttps://enplusone.bio/

Last Round

VC Round

Feb 19, 2025

Total Funding Raised

$12M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

EnPlusOne Biosciences is a biotechnology company that developed ezRNA™, an enzymatic-based RNA synthesis platform designed to manufacture RNA oligonucleotides for therapeutic applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Pharma Supply Chain, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

enzymatic RNA synthesisRNA manufacturingRNA synthesis platformRNA oligonucleotidestherapeutic RNAcustom RNA synthesisRNA CDMOmodified RNAsiRNAguide RNAgRNAantisense oligonucleotidesASOtemplate-free synthesisengineered enzymesgreen chemistry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EnPlusOne Biosciences Comparables

Compare EnPlusOne Biosciences with similar companies based on industry and business-model similarity.

EnPlusOne Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Codexis
74%
Ribbon Bio
72%
Ansa Biotechnologies
70%

EnPlusOne Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 19, 2025
SeedSep 30, 2022

EnPlusOne Biosciences Investors

Notable investors and investment history

EnPlusOne Biosciences investors
InvestorRounds
Northpond VenturesVC Round, Seed
Breakout VenturesSeed, VC Round
Coatue ManagementSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 23, 2026

    Monthly visitors increased 66% MoM, reaching 1K.

  • Mar 3, 2026

    Monthly visitors increased 30% MoM.

EnPlusOne Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EnPlusOne Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EnPlusOne Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersWatertown, Massachusetts
Employee Range26
Year Founded2022
Last FundingFeb 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?